Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
- Tabchy, A.
- Valero, V.
- Vidaurre, T.
- Lluch, A.
- Gomez, H.
- Martin, M.
- Qi, Y.
- Barajas-Figueroa, L.J.
- Souchon, E.
- Coutant, C.
- Doimi, F.D.
- Ibrahim, N.K.
- Gong, Y.
- Hortobagyi, G.N.
- Hess, K.R.
- Symmans, W.F.
- Pusztai, L.
ISSN: 1078-0432, 1557-3265
Year of publication: 2010
Volume: 16
Issue: 21
Pages: 5351-5361
Type: Article